The bidirectional p53-Wrap53β promoter is controlled by common cis- and trans-regulatory elements

Gene

Volumn 538, Issue 1, 2014, Pages 138-149

  Polson, Amanda ^a   Reisman, David ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bidirectional; P53; Promoter; Reporter vector; Wrap53

Indexed keywords

BIDIRECTIONAL; P53; PROMOTER; REPORTER VECTOR; WRAP53;

3T3 CELLS; ANIMALS; MICE; MUTATION; PROMOTER REGIONS, GENETIC; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84893767338     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.12.046     Document Type: Article

References (43)

1. Alonso S., et al. The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79. Hum. Hered. 2009, 69:34-44.
2. Bachl J., et al. The Ig mutator is dependent on the presence, position, and orientation of the large intron enhancer. Proc. Natl. Acad. Sci. 1998, 95:2396-2399.
3. Balint E., Reisman D. Elevated transcription of the p53 gene contributes to high level expression of mutant p53 in Burkitt's lymphomas. Cancer Res. 1996, 56:1648-1653.
4. Beckerman R., Prives C. Transcriptional regulation by p53. Cold Spring Harb. Perspect. Biol. 2010, 2. (no 8).
5. Boggs K., Reisman D. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 2006, 00:1-12.
6. Boggs K., Reisman D. C/EBPβ participates in regulating transcription of the p53 gene in response to mitogen stimulation. J. Biol. Chem. 2007, 282:7982-7990.
7. Boggs K., Henderson B., Reisman D. RBP-Jκ binds to and represses transcription of the p53 tumor suppressor gene. Cell Biol. Int. 2008, 33:318-324.
8. Engstrom P.G., et al. Complex loci of the human and mouse genome. PLoS Genet. 2006, 2(4):e47.
9. Fish J., et al. Hypoxia-inducible expression of a cis-antisense transcript inhibits endothelial nitric-oxide synthase. JBC 2007, 282:15652-15666.
10. Garcia-Closas M., et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int. J. Cancer 2007, 121:2532-2538.
11. GenBank Database Accessed from:. http://www.ncbi.nlm.nih.gov/genbank/.
12. Hale T.K., Braithwaite A.W. Identification of an upstream region of the mouse p53 promoter critical for transcriptional expression. Nucleic Acids Res. 1995, 23:663-669.
13. Hu H., Wulf G.M. The amplifier effect: how Pin1 empowers mutant p53. Breast Cancer Res. 2011, 13(5):315.
14. Khoo K., Mayer S., Fersht A.R. Effects of stability on the biological function of p53 Manuscript M109.033183. http://www.jbc.org/cgi/doi/10.1074/jbc.M109.033183.
15. Lapidot M., Pilpel Y. Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep. 2006, 7(12):1216-1222.
16. Lasham A., et al. The Y-box binding protein, TB1, is a potential negative regulator of the p53 tumor suppressor. J. Biol. Chem. 2003, 278:35516-35523.
17. Lee M., et al. Characterization of nuclear factors binding to AT-rich element in the rat p53 promoter. J. Cell. Biochem. 2001, 80:580-588.
18. Loging W., Reisman D. Transcriptional regulation of the p53 tumor suppressor gene. Cancer Biol. 1998, 8:317-332.
19. Mahmoudi S., et al. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol. Cell 2009, 33:462-471.
20. Mahmoudi S., et al. Wrap53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS 2010, 8(11):1-16.
21. Mahmoudi S., et al. Wrap53 promotes cancer cell survival and is a potential target for cancer therapy. Cell Death Dis. 2011, 2:e114.
22. Means A.L., Farnham P.J. Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site. Mol. Cell. Biol. 1990, 10:653-661.
23. Misra S., et al. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells. Mol. Cancer 2010, 9(50).
24. Polson A., Takahashi P., Reisman D. Chromatin immunoprecipitation (ChIP) analysis demonstrates coordinated binding of two transcription factors to the promoter of the p53 tumor suppressor gene. Cell Biol. Int. 2010, 34(9):883-891.
25. Polson A., Durrett E., Reisman D. A bidirectional reporter vector for the analysis of the p53/WDR79 dual regulatory element. Plasmid 2011, 66(3):169-179.
26. Raman V., et al. Conrol of p53 transcription by HOXA5 may play a role in breast cancer. Nature 2000, 405:974-978.
27. Reisman D., Rotter V. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 1993, 21(2):345-350.
28. Reisman D., Elkind N.B., Roy B., Beamon J., Rotter V. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 1993, 4(2):57-65.
29. Reisman D., et al. Cloning and characterization of murine upstream sequences reveals positive regulatory elements. Gene 2001, 274:129-137.
30. Roy B., Reisman D. Positive and negative regulatory elements contribute to expression of the p53 tumor suppressor gene. Oncogene 1996, 13:2359-2366.
31. Saldana-Meyer R., Recillas-Targa F. Transcriptional and epigenetic regulation of the tumor suppressor gene. Epigenetics 2011, 6(9):1068-1077.
32. Seila A., et al. Divergent transcription. Cell Cycle 2009, 8(16):2557-2564.
33. Shay J.W., Wright W.E. Role of telomeres and telomerase in cancer. Semin. Cancer Biol. 2011, 21:349-359.
34. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell 1989, 57:103-113.
35. Solomon H., Madas S., Rotter V. Mutant p53 gain of function is interwoven into the halllmarks of cancer. J. Pathol. 2011, 225:475-478.
36. Takahashi P., Polson A., Reisman D. Elevated transcription of the p53 gene in early S-phase leads to rapid DNA-damage response during S-phase of the cell cycle. Apoptosis 2011, 16(9):950-958.
37. Takaoka A., et al. Integration of interferon-alpha/beta signaling to p53 responses in tumor suppression and antiviral defense. Nature 2003, 242:516-523.
38. Trinklein N., et al. An abundance of bidirectional promoters in the human genome. Genome Res. 2004, 14:62-66.
39. Venteicher A., Artandi S. TCAB1 driving telomerase to Cajal bodies. Cell Cycle 2009, 8(9):1329-1331.
40. Vogelstein B., et al. Surfing the p53 network. Nature 2000, 408:307-310.
41. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
42. Wang Q., et al. Searching for bidirectional promoters in Arabidopsis thaliana. BMC Bioinforma. 2009, 10(S29). 10.1186/1471-2105-10-S1-S29.
43. Zhao Y., Chen X.Q., Du J.Z. Cellular adaptation to hypoxia and p53 transcription regulation. J. Zhejiang Univ. (Sci.) 2009, 10(5):404-410.